{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:30:32Z","timestamp":1793896232441,"version":"4.8.0"},"reference-count":49,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2026,1,28]]},"DOI":"10.1080\/10428194.2025.2586079","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T11:52:39Z","timestamp":1763380359000},"page":"295-305","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Emerging first-line treatment approaches for mantle cell lymphoma"],"prefix":"10.1080","volume":"67","author":[{"given":"Changchun","family":"Deng","sequence":"first","affiliation":[{"name":"UH Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3318-5147","authenticated-orcid":false,"given":"Nikki","family":"Agarwal","sequence":"additional","affiliation":[{"name":"University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel D.","family":"Sindel","sequence":"additional","affiliation":[{"name":"UH Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199207000-00001"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022351"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx334"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022354"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep16010006"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005715"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.5.1288"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.133"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200920"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01294"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412096"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30685-5"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-531327"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00605"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30185-5"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009744"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236089"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201817"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00690"},{"key":"e_1_3_4_22_1","first-page":"LB3439","volume-title":"European Hematology Association (EHA) Annual Meeting","author":"Wang ML","year":"2024","unstructured":"Wang ML, et\u00a0al. Acalabrutinib plus bendamustine and rituximab in untreated mantle cell lymphoma (MCL): results from the phase 3, double-blind, placebo-controlled ECHO trial in European Hematology Association (EHA) Annual Meeting. ; 2024. p. p. LB3439."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70093_46"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.1825"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-147025"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14241"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00739-X"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01780"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13929"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001355"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-194641"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00184-3"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70093_137"},{"key":"e_1_3_4_34_1","volume-title":"Role of Autologous Stem Cell Transplantation in the Context of Ibrutinib-Containing First-Line Treatment in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network","author":"Dreyling M","unstructured":"Dreyling M, et\u00a0al. Role of Autologous Stem Cell Transplantation in the Context of Ibrutinib-Containing First-Line Treatment in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network. Blood. 2024;144(S1):240."},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505237"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-859769"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009992"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70093_135"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00638-0"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011152"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199710"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01432-1"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-206042"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715519"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012424"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-797019"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779736"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025563"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401532"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70093_45"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2025.2586079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:34:09Z","timestamp":1772760849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2025.2586079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,28]]}},"alternative-id":["10.1080\/10428194.2025.2586079"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2025.2586079","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}